DAMORA THERAPEUTICS
Antibodies for therapeutic purposes; Pharmaceutical preparations for the treatment of cancer, myeloproliferative disorders, and hematological disorders; House mark for pharmaceuticals for the treatment of cancer, myeloproliferative disorders, and hematological disorders
Pending · October 23, 2025 · 99458830 ·